Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
This editorial discusses a novel basal insulin analog, insulin degludec. It describes the limitations of existing basal insulins, and builds the case for a better analog. The editorial discusses the evidence to support the efficacy, safety, tolerability, and flexibility of degludec, and assesses its...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Healthcare
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889334/ |